Ledger.Open graph →
SEC Form D · filed December 10, 2021

DMC Biotechnologies, Inc

Offering
$43.5M
Sold
$33.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Boulder, CO
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Rob D. Van Der Meij · Boulder, CODirectorCarolyn D. Fritz · Boulder, CODirectorDoug D. Cameron · Boulder, CODirectorMichael D. Lynch · Boulder, CODirectorMatthew L. Lipscomb · Boulder, COExec · DirectorAlastair D. Cooper · Boulder, CODirectorJosko D. Bobanovic · Boulder, CODirectorJames F. Oliviero, Iii · Waltham, MADirectorKelly Watters · Telluride, CODirectorBrian M. Good · Los Angeles, CADirectorAndrew M. Peltz · Los Angeles, CAExec · DirectorHarlan M. Peltz · Los Angeles, CADirectorCarla R. Hartzenberg · Vancouver, British Columbia, CanadaDirectorJoseph G. Machado · Boston, MADirectorRonghui Gu · New York, NYDirectorZhong Shao · New York, NYDirectorMuhan Zou · New York, NYExec · DirectorManivannan Shanmugam · Frisco, TXDirectorBryan A. Helmkamp · New York, NYDirectorLarry N. Feinberg · GREENWICH, CTDirectorDarell L. Krasnoff · LOS ANGELES, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗